# Efficacy of Two Onabotulinum Toxin Doses

> **NCT03388086** · — · COMPLETED · sponsor: **Swiss Paraplegic Research, Nottwil** · enrollment: 56 (actual)

## Conditions studied

- Neurogenic Bladder
- Overactive Detrusor

## Interventions

- **DRUG:** Injection of Onabotulinum toxin

## Key facts

- **NCT ID:** NCT03388086
- **Lead sponsor:** Swiss Paraplegic Research, Nottwil
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-01
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-07-31
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2019-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03388086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03388086, "Efficacy of Two Onabotulinum Toxin Doses". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03388086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*